ILiAD Biotechnologies

ILiAD Biotechnologies is a privately held, clinical stage biotechnology company developing treatments for human disease caused by Bordetella pertussis. 

Paraglider over Lake Tahoe
Biotech

Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders

Vincerx acquisition leads to C-suite shake-up. ILiAD COO dies in hit and run. Avalo turns the page with new strategy chief.
Fierce 15 Hero

Introducing Fierce Biotech's 2024 Fierce 15

Aug 5, 2024 6:00am